PR Case Studies - Schwartz MSL


Pharmaceutical and Biotech Public Relations

	HTG
	InnoCentive
	Scancell


Business and Financial Services Public Relations

Business Software and Solutions Public Relations

Cleantech and Green Public Relations

Cloud Computing and Virtualization

Consumer Public Relations

Emerging Technology Public Relations

Healthcare IT Public Relations

Materials Science & Semiconductor Public Relations

Medical Device and Diagnostics Public Relations

Networking, Wireless and Telecom Public Relations

Security Public Relations

Pharmaceutical and Biotech Public Relations

HTG
High Throughput Genomics, Inc., (HTG), is a provider of transcriptomic technology and services. HTG’s technology opens a new era of drug discovery and allows companies to identify new drug compounds, quickly eliminate less promising compounds and bring new drugs to market faster. HTG is the first company to commercialize this technology. HTG is online at www.htgenomics.com.

InnoCentive
The leader in on-demand innovation.

Scancell
Scancell was to start Phase I trials in Nottingham, UK for a new generation of highly-effective immunotherapy approaches for treating an existing cancer and preventing reoccurrence. The challenge for Schwartz was to explain the complex technology involved in DNA vaccines and distinguish Scancell’s melanoma candidate treatment from two other melanoma vaccines currently in trials.

"I felt compelled to write you this morning because your firm has had one heck of an impact on my company and I thought you deserved to know. I'm not an easy client to please, nor an easy person to work with daily, so that alone should say something about how special your employees truly are. Thank you for giving JobKite a sense of pride we have been longing for."

Heather Galler,
CEO,
JobKite